Management of epidural hematomas in pediatric patients presenting with a GCS of 14 or better

Michael T Bounajem1, D Clay Samples2, David J Wallace2

  • 1Long School of Medicine, University of Texas Health - San Antonio, San Antonio, TX, USA.

Insights

Pediatric epidural hematoma (PEDH) management guidelines are unclear. This study identified high-risk factors for surgery in children with a Glasgow Coma Scale (GCS) of 14+, including hematoma size and location.

Area of Science:

  • Pediatric Neurosurgery
  • Trauma Surgery
  • Neurocritical Care

Background:

  • Pediatric epidural hematoma (PEDH) management lacks defined guidelines.
  • Optimal treatment strategies for PEDH require further characterization.
  • Identifying predictors for surgical intervention is crucial for patient outcomes.

Purpose of the Study:

  • To characterize the disease course of PEDH in pediatric patients with a presenting Glasgow Coma Scale (GCS) of 14+.
  • To identify high-risk features associated with progression to surgical intervention in PEDH.
  • To inform clinical decision-making for non-operative management of PEDH.

Main Methods:

  • Retrospective chart review of a prospectively maintained trauma database.
  • Inclusion criteria: pediatric patients (6 months to 18 years) with PEDH (2006-2016).
  • Analysis of clinical data, head imaging (hematoma size, location, midline shift), and treatment outcomes.

Main Results:

  • Of 117 patients with GCS 14+, 24 (21%) required surgery.
  • Surgical indications included GCS decline (40%), hematoma size (21%), neurological deficit (20%), and imaging progression (12%).
  • Multilobar hematomas (OR: 24.8) and proximity to sinuses increased surgical likelihood; a thickness:biparietal diameter ratio ≤0.15 predicted conservative management (95.7%).

Conclusions:

  • Approximately 21% of pediatric patients with PEDH and GCS 14+ underwent surgery.
  • High-risk factors for surgery include large hematoma thickness, multilobar involvement, and transverse sinus proximity.
  • A thickness:biparietal skull diameter ratio <0.15 strongly suggests conservative management is appropriate.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
261
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
250
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
692
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
407